News

EMH Health System announces series of executive additions

The health system stated in a press release that the changes introduce “fresh, new perspectives” and add “balance to its existing disciplines.”

ELYRIA, Ohio — EMH Regional Healthcare System made a trio of changes to its executive staff that included creating a new position. The health system stated in a press release that the changes introduce “fresh, new perspectives” and add “balance to its existing disciplines.”

The promotions are:

  • Jill Cooksey, the new vice president of nursing/chief nursing officer, who will oversee inpatient nursing throughout the system.
  • Dr. Douglas McDonald, the new vice president of medical affairs/chief medical officer, who will act as the liaison between system physicians and the executive team.
  • Charlotte Wray, the new vice president of clinical operations/chief clinical officer, which is a new position.  Wray will oversee the emergency department, cardiovascular services, surgery and other areas that have significant inpatient and outpatient activity.
sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

All three executives previously held positions within EMH. The health system got a new CEO in April, Dr. Donald Sheldon, who succeeded the late Kevin Martin.